Associate Director/Director, Biomarker, Translational Sciences - United States
|External Posting Title||Associate Director/Director, Biomarker, Translational Sciences|
|Job Description||Development Biomarkers is seeking a highly motivated, experienced scientist to join a dynamic team engaged in the discovery and development of novel biomarkers for neurodegeneration, autoimmune and neuroinflammation disease areas. This particular role is required to coordinate and lead department-wide biomarker efforts for pivotal late stage program(s) in neurodegeneration. The successful candidate will be a proven leader, capable of multitasking, setting goals, priorities, planning timelines and driving execution. Exceptional communication and collaboration skills are essential. Strategic, critical thinking coupled with the ability to quickly assimilate, integrate and respond to emerging information are necessary.|
• Define key questions, develop and execute cohesive, decision enabling biomarker plans for late stage asset(s).
• Serve as single point of contact, representing all biomarker scientific areas (imaging, tissue-based and biofluid biomarkers) in support of late stage asset(s).
• Represent Biomarkers department on Program and Clinical Development teams, responsible for integrating biomarker strategy into overall development program; and execution thereof.
• Support the planning and execution of clinical trials; Author and review relevant sections of clinical protocols, medical affairs and regulatory documents/filings;
• Liaise with external collaborators and vendors, as well as clinical operations, BD, regulatory, research, medical and commercial groups internally
• Coordinate departmental resources to achieve team goals and effectively convey information between cross-functional and departmental stakeholders
• Provide scientific expertise and interpretation of biomarker data to inform statistical analysis plans
• Prepare, review and deliver scientific presentations for internal/external audiences and author related manuscripts
• Bring new assay/platform capabilities in house to support clinical biomarker analysis and provide technical expertise across biomarker platforms (e.g. ELISA, qPCR, ISH, IHC, NGS, imaging, flow cytometry)
|Location||Cambridge, MA, US|
• Five plus years biomarker development experience in industry setting with exceptional verbal and written communication skills; proven ability able to deliver clear, concise presentations tailored to different audiences
• Demonstrated leadership in translational sciences including biomarker identification, assay development and implementation to support program go/no-go decisions, patient selection and CDx development
• Strong understanding of drug discovery & development, especially late stage development, approval process and life cycle management
• Ability to quickly absorb new information and develop an understanding of the relevant biology, pathway, MOA, disease indication(s) and potential patient selection/stratification strategies for multiple programs
• Proven scientific leadership of cross-functional teams, managing people and complex projects
• Demonstrated ability to influence without authority and efficiently drive alignment amongst multiple stakeholders to efficiently progress programs/projects
• Experience managing scientific collaborations and contracted research
• Versed in relevant technologies with strong understanding of inherent advantages and limitations thereof in context of clinical implementation, including potential for diagnostic development
• Ability to prioritize and deploy resources effectively and appropriately to meet key goals and timelines
• Must be a highly flexible, results oriented, independent self-starter who enjoys working in a fast paced dynamic environment.
|Education||PhD in a life science related field|
|About Biogen||Corporate Overview|
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis (MS), has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Biogen also manufactures and commercializes biosimilars of advanced biologics. Our global organization of nearly 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients with few or no treatment options.
One of the pioneers in biotechnology, Biogen was founded in 1978 and today serves patients in nearly 90 countries. Our global headquarters and R&D operations are located in Cambridge, Massachusetts, with an international headquarters in Zug, Switzerland, world-class manufacturing facilities in Research Triangle Park, North Carolina, USA and Hillerod, Denmark, and affiliate locations around the world.
We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry. To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments.
For nearly two decades Biogen has led in the research and development of new therapies to treat MS, including the most prescribed oral treatment in the world. Now our research is driving revolutionary new MS treatments with the goal of reversing or even repairing damage caused by the disease. We are now applying our neurological expertise to solve some of most challenging and complex diseases of the brain, including Alzheimer’s disease, Parkinson’s disease, and ALS. As we uncover new insights into human biology, Biogen is employing cutting-edge technologies to discover potential treatments for rare and genetic disorders.
Biogen is revolutionizing biologics manufacturing, developing the industry’s most advanced plants and processes. This expertise is used to produce both original innovative therapies and biosimilars that expand patient access to lower-cost medicines.
Our Corporate Citizenship
The same intellectual discipline and passion that drives our science is reflected in our corporate citizenship, environmental sustainability, and commitment to diversity and inclusion. As a company, we are focused on improving science education and limiting the impact of our company on the environment. In 2015, we became a carbon neutral company and ranked first place on Newsweek’s 2015 Green Rankings, and we are an industry leader on the Dow Jones Sustainability World Index. Biogen was named to Science’s list of Top Employers of 2015 and in 2017 received a perfect score of 100 for the fourth consecutive year on the Human Rights Campaign (HRC) Corporate Equality Index, which also named Biogen as one of its Best Places to Work.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Please be advised that all legitimate correspondence from a Biogen employee will come from "@biogen.com" email accounts.
Nearest Major Market: Cambridge
Nearest Secondary Market: Boston
Job Segment: Biotech, Manager, Statistics, Scientific, Science, Management, Data, Research, Engineering